Gerner S, Kuramatsu J, Sembill J, Sprügel M, Hagen M, Knappe RU, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker JC, Rizos T, Volkmann J, Muellges W, Kraft P, Schubert AL, Erbguth F, Nueckel M, Schellinger PD, Glahn J, Knappe UJ, Fink GR, Dohmen C, Stetefeld H, Fisse AL, Minnerup J, Hagemann G, Rakers F, Reichmann H, Schneider H, Rahmig J, Ludolph AC, Stoesser S, Neugebauer H, Roether J, Michels P, Schwarz M, Reimann G, Baezner H, Schwert H, Classen J, Michalski D, Grau A, Palm F, Urbanek C, Woehrle JC, Alshammari F, Horn M, Bahner D, Witte OW, Guenther A, Hamann GF, Engelhorn T, Lücking H, Dörfler A, Schwab S, Huttner H (2019)
Publication Type: Journal article
Publication year: 2019
Book Volume: 50
Pages Range: 1392-1402
Journal Issue: 6
DOI: 10.1161/STROKEAHA.118.023492
Background and Purpose Given inconclusive studies, it is debated whether clinical and imaging characteristics, as well as functional outcome, differ among patients with intracerebral hemorrhage (ICH) related to vitamin K antagonists (VKA) versus non-vitamin K antagonist (NOAC)-related ICH. Notably, clinical characteristics according to different NOAC agents and dosages are not established.
APA:
Gerner, S., Kuramatsu, J., Sembill, J., Sprügel, M., Hagen, M., Knappe, R.U.,... Huttner, H. (2019). Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke, 50(6), 1392-1402. https://doi.org/10.1161/STROKEAHA.118.023492
MLA:
Gerner, Stefan, et al. "Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage." Stroke 50.6 (2019): 1392-1402.
BibTeX: Download